Stock Events

Stock Events

CRISPR Therapeutics (C2RS34.SA) Q2 2024 Earnings

8MayConfirmed

Q4 2023

Q2 2024

-7.28

-3.04

1.19

5.43

Details

Expected EPS

-6.923849649399999

Actual EPS

-7.275554

Surprise EPS

-0.35

Surprise Percent

+5.08%

Description

CRISPR Therapeutics (C2RS34.SA) has reported earnings of -7.275554 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.